BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27843131)

  • 1. Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.
    Lai YM; Yao WY; He Y; Jiang X; Gu YB; Chen MH; Liu YL; Yuan YZ; Qian JM
    Gut Liver; 2017 Mar; 11(2):216-225. PubMed ID: 27843131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy.
    Li N; Mao J; Tang H; Zhu L; Tan X; Bi J; Wu H; Chen X; Wang Y
    J Clin Apher; 2020 Aug; 35(4):271-280. PubMed ID: 32378240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
    Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
    BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
    Ishiguro Y; Ohmori T; Umemura K; Iizuka M
    Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
    Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
    Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis.
    Yanagisawa K; Murakami M; Kondo Y; Oguma S; Kobayashi S; Miyasaka H; Shinohara T; Tomori A; Nakano Y; Furuhata S; Ikezoe M
    Ther Apher Dial; 2019 Jun; 23(3):217-223. PubMed ID: 31025815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.
    Iida T; Ikeya K; Kato M; Abe J; Yamamoto M; Watanabe F; Sugimoto K; Hanai H
    Digestion; 2017; 96(2):119-126. PubMed ID: 28796990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.
    Sacco R; Tanaka T; Yamamoto T; Bresci G; Saniabadi AR
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):327-33. PubMed ID: 25160857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
    Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
    World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study.
    Yamamoto T; Umegae S; Matsumoto K
    J Gastroenterol; 2011 Aug; 46(8):1003-9. PubMed ID: 21681409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study.
    Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Sakatani A; Takahashi K; Tanaka K; Serikawa S; Ando K; Kashima S; Muto M; Inaba Y; Moriichi K; Tanabe H; Okumura T; Fujiya M
    J Clin Apher; 2023 Aug; 38(4):406-421. PubMed ID: 36636880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
    Yokoyama Y; Kawai M; Fukunaga K; Kamikozuru K; Nagase K; Nogami K; Kono T; Ohda Y; Iimuro M; Hida N; Nakamura S; Miwa H; Matsumoto T
    BMC Gastroenterol; 2013 Feb; 13():27. PubMed ID: 23399416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.
    Takeda S; Sato T; Katsuno T; Nakagawa T; Noguchi Y; Yokosuka O; Saito Y
    Dig Dis Sci; 2010 Jul; 55(7):1886-95. PubMed ID: 19908144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.
    Tominaga K; Nakano M; Hoshino M; Kanke K; Hiraishi H
    BMC Gastroenterol; 2013 Mar; 13():41. PubMed ID: 23452668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
    Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
    Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.